LES Licensing Executives Society
USA & CanadaLESI OrganizationTrustee Login

About Us
Membership
Calendar of Events
Meetings
Education
CLP
Local Chapters
Industry Sectors
Professional Interest Committees
Publications
Press Room
Licensing Resouces
Search/Sitemap


search

LES 2004 Annual Meeting:
Solutions Through Synergy

October 17-21 | Marriott Copley Place
Boston, MA
Download Annual Meeting Brochure

Meeting Committee

Meeting Program:

Partnering Meetings

Registration:

Sponsors:

Tech Fair

Sign up for the LES Member Cabaret

Apply for a spot in the LES Band

Miscellaneous Info

PDS Workshops

Each of the Professional Development Series (PDS) Workshops meets one of the PDS Workshop Requirements for completing the Intermediate level of the Series. It is also open to all meeting attendees on a space-available basis. Because class size is limited to 25, both PDS students and other interested participants are asked to sign up for each of the Workshops in advance by contacting Judy Walter (703-299-8211; jwalter@les.org). Tickets for any remaining spaces will be made available at the LES Registration desk onsite at the Meeting. Visit the Education Section for more information about the Professional Development Series.


Monday, Oct. 18
2:00-5:00 p.m.

Portfolio Analysis/Risk Assessment
(IA STRATEGY)

Paul Germeraad
President, Intellectual Assets, Inc.

Portfolio analysis is a critical element and one of the first steps in good intellectual asset management. This workshop's case study format explores a sample portfolio in a hands-on manner, identifying its strengths, weaknesses, opportunities and threats. During the workshop, tools are used to explore the portfolio from specific perspectives: geographic scope; likely validity and value in protecting the company's ongoing business; likely size, depth and breadth for licensing; likely sustainability, and finally its direction versus competitors. Knowing this information allows the workshop participants to recommend which art to utilize as building blocks for further R&D, which to license to others, and which to donate or abandon. After this hands-on experience, workshop participants will be able to more productively analyze, or re-analyze, their own company's portfolio and confidently recommend the appropriate actions to be undertaken. Emphasis is placed on understanding the business context in which the portfolio can best create value, as well as on tools and methods that generate the most insight with the least amount of time expended.


Tuesday, Oct. 19
2:00-5:00 p.m.

Licensing Federal Biomedical Technology
(LICENSING)

Charles M. Maynard
Technology Transfer Specialist, National Cancer Institute Technology Transfer, National Institutes of Health (NIH)

George H. Keller
Licensing Specialist, Office of Technology Transfer, National Institutes of Health (NIH)

Federal biomedical technology development occurs primarily at the National Institutes of Health (NIH) and the Centers for Disease Control (CDC) and the Food and Drug Administration (FDA) and to a lesser degree at various government agencies. The range of available technologies is vast, and in addition, multiple licensing options and other government opportunities can greatly enhance the value of the license agreement. There are also obligations that accompany a federal biomedical license agreement that potential licensors may find unique. The purpose of this interactive workshop is to help participants overcome the cultural challenges that exist in accessing and acquiring available technologies and other opportunities, principally by the NIH through the Office of Technology Transfer (OTT). This Workshop is designed for the key decision makers such as the business development, legal and licensing professionals to answer the question "Once the technology is identified, what are some key considerations in achieving an effective partnership through the licensing process?" After completing this workshop, which will include some case studies, participants will be able to use new techniques to improve and speed up the acquisition of federal biomedical technology for their institutions.


Wednesday, Oct. 20
2:00-5:00 p.m.

Implementing Valuation Methods
(VALUATION)

Robert Vigil
Vice President, Analysis Group, Inc.

Mohan P. Rao
Managing Director, Charles River Associates

Penelope Bahn
Corporate Finance, Transaction Advisory Services, Ernst & Young LLP

This interactive workshop, developed in collaboration with the LES Valuation Committee, will focus on implementing advanced valuation methods. It assumes that participants have a working knowledge of the basic Income, Cost and Market Approaches to IP valuation. This workshop goes beyond the basics through descriptions and hands-on use of discounted cash flow (DCF), Monte Carlo and Real Options applications. Participants will explore the relationship among these tools, along with the strengths and shortcomings of each, as well as commercial and customized methods by which to perform the analyses. In small teams, participants will work through applications of each tool and present their results to the larger group for comment and critique.



site designed and programmed by Americaneagle.com, Inc.  
LES Home | About Us | Membership | Calendar of Events | Meetings | Education | Press Room | Publications
Local Chapters | Search/Sitemap | Member-Login | Foundation | Industry Sectors | Professional Interest Committees | LESI | Trustee Login | Contact Us